Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pebble Investment Partners LLP is a venture capital firm based in Norwich, Norfolk, UK, specializing in early-stage investments in the plant and microbial sectors. Founded by Dr. Victor Christou, the firm is dedicated to addressing global challenges such as food security, health threats, and environmental degradation. The firm operates from the John Innes Centre, a leading research institution in plant science and microbiology, which aligns with its investment focus.
Currently, Pebble Investment Partners is positioned to invest in a range of early-stage companies, particularly those emerging from the Norwich Research Park ecosystem. Although specific metrics regarding fund size and portfolio count are not disclosed, the firm is expected to leverage its strategic location and expertise to identify promising ventures. The firm is FCA-registered, ensuring compliance with financial regulations.
Pebble Investment Partners LLP focuses on financing early-stage companies that are commercializing innovations in the plant and microbial sectors. Their investment strategy encompasses pre-seed to seed+ stages, with a particular emphasis on biotech, agtech, healthcare, and climate sectors. The firm seeks to invest in companies that aim to increase crop yields, develop pest-resistant crops, and improve agricultural practices.
Additionally, Pebble emphasizes the health benefits associated with plants and microbes, aiming to enhance dietary quality and reduce healthcare burdens. The firm also addresses environmental challenges by promoting practices that reduce reliance on fossil-based fertilizers and improve soil health. This comprehensive approach positions Pebble as a key player in supporting sustainable agricultural innovations.
Currently, Pebble Investment Partners does not publicly list specific portfolio companies. However, the firm is expected to invest in sectors such as agri-biotech, industrial biotech, plant genomics, and microbiology spinouts, particularly those emerging from the Norwich Research Park ecosystem. Given Dr. Victor Christou's extensive background and connections, investments are anticipated in companies that align with their focus on plant and microbial innovations.
While no notable exits or current portfolio companies are documented, the firm's strategic emphasis on addressing food security and environmental sustainability suggests that future investments will likely target startups innovating in these critical areas.
Dr. Victor Christou - Managing Director
Dr. Victor Christou holds a PhD in Chemistry from Imperial College London and is a Sloan Fellow at Stanford University. He has a distinguished background as a former Royal Society University Research Fellow at the University of Oxford and has held an academic post at UC Berkeley. Dr. Christou founded Opsys, a company focused on organic electronics and OLEDs, which was sold to Cambridge Display Technology. He served as CEO of Cambridge Innovation Capital for five years, raising £225 million across two funding rounds. His portfolio during this tenure included notable companies such as CMR Surgical and Microbiotica. Dr. Christou is also the Chair of St John's Innovation Centre and was listed in the Global University Venturing Powerlist 2018.
To pitch Pebble Investment Partners, founders should use the contact form available on their website at pebbleinvestmentpartners.com. It is important to include a comprehensive pitch deck that outlines the innovation, market opportunity, and team qualifications. Founders should expect a response time that may vary, but it is advisable to follow up if no communication is received within a few weeks.
No recent news or updates have been reported for Pebble Investment Partners LLP. The firm maintains a focused approach on its mission, but there are no public announcements regarding new investments, exits, or other significant activities.
What are Pebble Investment Partners' investment criteria?
Pebble Investment Partners invests in early-stage companies within the plant and microbial sectors, focusing on innovations that enhance agricultural practices and health benefits. They prioritize companies that address global challenges such as food security and environmental sustainability.
How can founders pitch to Pebble Investment Partners?
Founders can pitch their ideas through the firm's website at pebbleinvestmentpartners.com. It is advisable to include detailed information about the innovation, market potential, and team background in the pitch deck.
What makes Pebble Investment Partners different from other venture capital firms?
Pebble Investment Partners distinguishes itself by its exclusive focus on the plant and microbial sectors, leveraging the expertise and resources of the Norwich Research Park. Their commitment to addressing critical global challenges aligns well with startups developing sustainable solutions.
What is the geographic scope of Pebble Investment Partners?
The firm primarily focuses on investments within the United Kingdom and Europe, targeting early-stage companies that are innovating in the plant and microbial sectors.
What is the typical check size for investments made by Pebble Investment Partners?
Specific check sizes are not disclosed, but the firm invests in pre-seed to seed+ stages, indicating a range that typically aligns with early-stage funding requirements.
What kind of post-investment involvement can founders expect from Pebble Investment Partners?
Pebble Investment Partners provides not only capital but also strategic guidance and industry expertise to its portfolio companies, leveraging their extensive network and knowledge base.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.